|
CASD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.766200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.982000E-02 |
| Normal-vs-Stage2 |
3.263800E-01 |
| Normal-vs-Stage3 |
1.401870E-02 |
| Normal-vs-Stage4 |
1.209800E-02 |
| Stage1-vs-Stage2 |
9.139200E-01 |
| Stage1-vs-Stage3 |
1.447200E-01 |
| Stage1-vs-Stage4 |
2.100600E-01 |
| Stage2-vs-Stage3 |
3.387800E-01 |
| Stage2-vs-Stage4 |
4.022600E-01 |
| Stage3-vs-Stage4 |
9.330800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.177600E-02 |
| Normal-vs-AfricanAmerican |
1.378080E-04 |
| Normal-vs-Asian |
6.647800E-01 |
| Caucasian-vs-AfricanAmerican |
4.356100E-03 |
| Caucasian-vs-Asian |
7.713600E-01 |
| AfricanAmerican-vs-Asian |
1.236750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.238300E-02 |
| Normal-vs-Female |
2.674100E-02 |
| Male-vs-Female |
6.649200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.612300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.269800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.360500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.240620E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.379600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.606600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.023200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.226800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.561200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.057100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.037800E-01 |
| Normal-vs-Grade 2 |
4.313800E-01 |
| Normal-vs-Grade 3 |
7.183800E-04 |
| Normal-vs-Grade 4 |
4.06910000000371E-05 |
| Grade 1-vs-Grade 2 |
5.122000E-01 |
| Grade 1-vs-Grade 3 |
5.325800E-02 |
| Grade 1-vs-Grade 4 |
6.975300E-03 |
| Grade 2-vs-Grade 3 |
4.684300E-03 |
| Grade 2-vs-Grade 4 |
8.07260000000865E-05 |
| Grade 3-vs-Grade 4 |
4.336100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.080600E-01 |
| Normal-vs-ccB subtype |
2.252000E-02 |
| ccA subtype-vs-ccB subtype |
2.396000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.651700E-02 |
| Normal-vs-N1 |
1.503960E-01 |
| N0-vs-N1 |
5.927600E-01 |
|
|
